121 related articles for article (PubMed ID: 15375537)
21. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
Persons DL; Hartmann LC; Herath JF; Borell TJ; Cliby WA; Keeney GL; Jenkins RB
Am J Pathol; 1993 Mar; 142(3):733-41. PubMed ID: 8096121
[TBL] [Abstract][Full Text] [Related]
22. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
[TBL] [Abstract][Full Text] [Related]
23. Detection of 20q13 gain by dual-color FISH in breast cancers.
Kobayashi Y; Esato K; Noshima S; Oga A; Sasaki K
Anticancer Res; 2000; 20(1B):531-5. PubMed ID: 10769720
[TBL] [Abstract][Full Text] [Related]
24. Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma.
Kang JU; Koo SH; Jeong TE; Kwon KC; Park JW; Jeon CH
Cancer Genet Cytogenet; 2006 Jan; 164(1):32-8. PubMed ID: 16364760
[TBL] [Abstract][Full Text] [Related]
25. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
Panani AD; Babanaraki A; Malianga E; Roussos Ch
Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
[TBL] [Abstract][Full Text] [Related]
26. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
[TBL] [Abstract][Full Text] [Related]
27. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
[TBL] [Abstract][Full Text] [Related]
28. 11q23-24 loss is associated with chromosomal instability in endometrial cancer.
Kawasaki K; Suehiro Y; Umayahara K; Morioka H; Ito T; Saito T; Tsukamoto N; Sugino N; Kato H; Sasaki K
Int J Mol Med; 2003 Nov; 12(5):727-31. PubMed ID: 14533001
[TBL] [Abstract][Full Text] [Related]
29. [New WHO classification of urothelial carcinoma of the urinary bladder].
Helpap B
Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352
[TBL] [Abstract][Full Text] [Related]
30. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
31. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
Panani AD; Roussos C
Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
[TBL] [Abstract][Full Text] [Related]
32. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
[TBL] [Abstract][Full Text] [Related]
33. Numerical aberrations of chromosomes 8, 9, 11, and 17 in squamous cell carcinoma of the pharynx and larynx: a fluorescence in situ hybridization and DNA flow cytometric analysis of 50 cases.
Hardisson D; Alvarez-Marcos C; Salas-Bustamante A; Alonso-Guervós M; Sastre N; Sampedro A
Oral Oncol; 2004 Apr; 40(4):409-17. PubMed ID: 14969820
[TBL] [Abstract][Full Text] [Related]
34. Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch.
Bubendorf L
Acta Cytol; 2011; 55(2):113-9. PubMed ID: 21325794
[TBL] [Abstract][Full Text] [Related]
35. Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium.
Steidl C; Simon R; Bürger H; Brinkschmidt C; Hertle L; Böcker W; Terpe HJ
J Pathol; 2002 Sep; 198(1):115-20. PubMed ID: 12210071
[TBL] [Abstract][Full Text] [Related]
36. Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening?
Panani AD; Kozirakis D; Anastasiou J; Babanaraki A; Malovrouvas D; Roussos C
Anticancer Res; 2006; 26(2A):1161-5. PubMed ID: 16619518
[TBL] [Abstract][Full Text] [Related]
37. The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinomas of the bladder.
Decaestecker C; van Velthoven R; Petein M; Janssen T; Salmon I; Pasteels JL; van Ham P; Schulman C; Kiss R
J Pathol; 1996 Mar; 178(3):274-83. PubMed ID: 8778332
[TBL] [Abstract][Full Text] [Related]
38. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M
J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498
[TBL] [Abstract][Full Text] [Related]
39. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
40. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder.
Morton MJ; Zhang S; Lopez-Beltran A; MacLennan GT; Eble JN; Montironi R; Sung MT; Tan PH; Zheng S; Zhou H; Cheng L
Clin Cancer Res; 2007 Oct; 13(20):6232-6. PubMed ID: 17947491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
